Single-nucleotide polymorphisms in DNA-repair genes and cutaneous melanoma

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 702, Issue 1, 2010, Pages 8-16

  Figl, Adina ^a,b   Scherer, Dominique ^a   Nagore, Eduardo ^c   Bermejo, Justo Lorenzo ^a,d   Botella Estrada, Rafael ^c   Gast, Andreas ^a   Thirumaran, Ranjit K ^a   Planelles, Dolores ^e   Hemminki, Kari ^a,f   Schadendorf, Dirk ^g   Kumar, Rajiv ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^d UNIVERSITY OF HEIDELBERG   (Germany)

^e Centro de Transfusion de la Comunidad Valenciana   (Spain)

^f KAROLINSKA INSTITUTE   (Sweden)

^g UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Combined analysis; DNA repair genes; Melanoma; Polymorphisms; Review; Risk

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CONTROLLED STUDY; DNA POLYMORPHISM; DNA REPAIR; GENETIC ASSOCIATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN CANCER;

DNA REPAIR; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MELANOMA; POLYMORPHISM, SINGLE NUCLEOTIDE; SKIN NEOPLASMS;

EID: 77956444537     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2010.06.011     Document Type: Article

References (78)

1. Leiter U., Garbe C. Epidemiology of melanoma and nonmelanoma skin cancer - the role of sunlight. Adv. Exp. Med. Biol. 2008, 624:89-103.
2. Buettner P.G., Leiter U., Eigentler T.K., Garbe C. Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society. Cancer 2005, 103:616-624.
3. Lasithiotakis K.G., Leiter U., Eigentler T., Breuninger H., Metzler G., Meier F., Garbe C. Improvement of overall survival of patients with cutaneous melanoma in Germany, 1976-2001: which factors contributed?. Cancer 2007, 109:1174-1182.
4. Hayward N.K. Genetics of melanoma predisposition. Oncogene 2003, 22:3053-3062.
5. Sekulic A., Haluska P., Miller A.J., Genebriera De Lamo J., Ejadi S., Pulido J.S., Salomao D.R., Thorland E.C., Vile R.G., Swanson D.L., Pockaj B.A., Laman S.D., Pittelkow M.R., Markovic S.N. Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin. Proc. 2008, 83:825-846.
6. Bishop D.T., Demenais F., Goldstein A.M., Bergman W., Bishop J.N., Bressac-de Paillerets B., Chompret A., Ghiorzo P., Gruis N., Hansson J., Harland M., Hayward N., Holland E.A., Mann G.J., Mantelli M., Nancarrow D., Platz A., Tucker M.A. Geographical variation in the penetrance of CDKN2A mutations for melanoma. J. Natl. Cancer Inst. 2002, 94:894-903.
7. Begg C.B., Orlow I., Hummer A.J., Armstrong B.K., Kricker A., Marrett L.D., Millikan R.C., Gruber S.B., Anton-Culver H., Zanetti R., Gallagher R.P., Dwyer T., Rebbeck T.R., Mitra N., Busam K., From L., Berwick M. Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J. Natl. Cancer Inst. 2005, 97:1507-1515.
8. Gudbjartsson D.F., Sulem P., Stacey S.N., Goldstein A.M., Rafnar T., Sigurgeirsson B., Benediktsdottir K.R., Thorisdottir K., Ragnarsson R., Sveinsdottir S.G., Magnusson V., Lindblom A., Kostulas K., Botella-Estrada R., Soriano V., Juberias P., Grasa M., Saez B., Andres R., Scherer D., Rudnai P., Gurzau E., Koppova K., Kiemeney L.A., Jakobsdottir M., Steinberg S., Helgason A., Gretarsdottir S., Tucker M.A., Mayordomo J.I., Nagore E., Kumar R., Hansson J., Olafsson J.H., Gulcher J., Kong A., Thorsteinsdottir U., Stefansson K. ASIP and TYR pigmentation variants associate with cutaneous melanoma and basal cell carcinoma. Nat. Genet. 2008, 40:886-891.
9. Nan H., Kraft P., Hunter D.J., Han J. Genetic variants in pigmentation genes, pigmentary phenotypes, and risk of skin cancer in Caucasians. Int. J. Cancer 2009, 125:909-917.
10. Wood R.D., Mitchell M., Lindahl T. Human DNA repair genes. Mutat. Res. 2005, 577:275-283.
11. Friedberg E.C. DNA damage and repair. Nature 2003, 421:436-440.
12. Cleaver J.E. Cancer in xeroderma pigmentosum and related disorders of DNA repair. Nat. Rev. Cancer 2005, 5:564-573.
13. David S.S., O'Shea V.L., Kundu S. Base-excision repair of oxidative DNA damage. Nature 2007, 447:941-950.
14. Li X., Heyer W.D. Homologous recombination in DNA repair and DNA damage tolerance. Cell Res. 2008, 18:99-113.
15. Li G.M. Mechanisms and functions of DNA mismatch repair. Cell Res. 2008, 18:85-98.
16. Li C., Wang L.E., Wei Q. DNA repair phenotype and cancer susceptibility - a mini review. Int. J. Cancer 2009, 124:999-1007.
17. Berwick M., Vineis P. Markers of DNA repair and susceptibility to cancer in humans: an epidemiologic review. J. Natl. Cancer Inst. 2000, 92:874-897.
18. Wei Q., Lee J.E., Gershenwald J.E., Ross M.I., Mansfield P.F., Strom S.S., Wang L.-E., Guo Z., Qiao Y., Amos C.I., Spitz M.R., Duvic M. Repair of UV light-induced DNA damage and risk of cutaneous malignant melanoma. J. Natl. Cancer Inst. 2003, 95:308-315.
19. Goode E.L., Ulrich C.M., Potter J.D. Polymorphisms in DNA repair genes and associations with cancer risk. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1513-1530.
20. Manuguerra M., Saletta F., Karagas M.R., Berwick M., Veglia F., Vineis P., Matullo G. XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review. Am. J. Epidemiol. 2006, 164:297-302.
21. Hung R.J., Hall J., Brennan P., Boffetta P. Genetic polymorphisms in the base excision repair pathway and cancer risk: a HuGE review. Am. J. Epidemiol. 2005, 162:925-942.
22. Clarkson S.G., Wood R.D. Polymorphisms in the human XPD (ERCC2) gene, DNA repair capacity and cancer susceptibility: an appraisal. DNA Repair (Amst) 2005, 4:1068-1074.
23. Winsey S.L., Haldar N.A., Marsh H.P., Bunce M., Marshall S.E., Harris A.L., Wojnarowska F., Welsh K.I. A Variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res. 2000, 60:5612-5616.
24. Han J., Hankinson S.E., Colditz G.A., Hunter D.J. Genetic variation in XRCC1, sun exposure, and risk of skin cancer. Br. J. Cancer 2004, 91:1604-1609.
25. Li C., Liu Z., Wang L.E., Strom S.S., Lee J.E., Gershenwald J.E., Ross M.I., Mansfield P.F., Cormier J.N., Prieto V.G., Duvic M., Grimm E.A., Wei Q. Genetic variants of the ADPRT, XRCC1 and APE1 genes and risk of cutaneous melanoma. Carcinogenesis 2006, 27:1894-1901.
26. Povey J.E., Darakhshan F., Robertson K., Bisset Y., Mekky M., Rees J., Doherty V., Kavanagh G., Anderson N., Campbell H., MacKie R.M., Melton D.W. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma. Carcinogenesis 2007, 28:1087-1093.
27. Duan Z., Shen H., Lee J.E., Gershenwald J.E., Ross M.I., Mansfield P.F., Duvic M., Strom S.S., Spitz M.R., Wei Q. DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma. Cancer Epidemiol. Biomarkers Prev. 2002, 11:1142-1143.
28. Han J., Colditz G.A., Samson L.D., Hunter D.J. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res. 2004, 64:3009-3013.
29. Bertram C.G., Gaut R.M., Barrett J.H., Randerson-Moor J., Whitaker L., Turner F., Bataille V., dos Santos Silva I., Swerdlow A.J., Bishop D.T., Newton J.A. Bishop an assessment of a variant of the DNA repair gene XRCC3 as a possible nevus or melanoma susceptibility genotype. J. Invest. Dermatol. 2004, 122:429-432.
30. Blankenburg S., Konig I.R., Moessner R., Laspe P., Thoms K.M., Krueger U., Khan S.G., Westphal G., Volkenandt M., Neumann C., Ziegler A., Kraemer K.H., Reich K., Emmert S. No association between three xeroderma pigmentosum group C and one group G gene polymorphisms and risk of cutaneous melanoma. Eur. J. Hum. Genet. 2005, 13:253-255.
31. Li C., Hu Z., Liu Z., Wang L.E., Strom S.S., Gershenwald J.E., Lee J.E., Ross M.I., Mansfield P.F., Cormier J.N., Prieto V.G., Duvic M., Grimm E.A., Wei Q. Polymorphisms in the DNA repair genes XPC, XPD, and XPG and risk of cutaneous melanoma: a case-control analysis. Cancer Epidemiol. Biomarkers Prev. 2006, 15:2526-2532.
32. Baccarelli A., Calista D., Minghetti P., Marinelli B., Albetti B., Tseng T., Hedayati M., Grossman L., Landi G., Struewing J.P., Landi M.T. XPD gene polymorphism and host characteristics in the association with cutaneous malignant melanoma risk. Br. J. Cancer 2004, 90:497-502.
33. Han J., Colditz G.A., Liu J.S., Hunter D.J. Genetic variation in XPD, sun exposure, and risk of skin cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1539-1544.
34. Debniak T., Scott R.J., Huzarski T., Byrski T., Masojc B., van de Wetering T., Serrano-Fernandez P., Gorski B., Cybulski C., Gronwald J., Debniak B., Maleszka R., Kladny J., Bieniek A., Nagay L., Haus O., Grzybowska E., Wandzel P., Niepsuj S., Narod S.A., Lubinski J. XPD common variants and their association with melanoma and breast cancer risk. Breast Cancer Res. Treat. 2006, 98:209-215.
35. Tomescu D., Kavanagh G., Ha T., Campbell H., Melton D.W. Nucleotide excision repair gene XPD polymorphisms and genetic predisposition to melanoma. Carcinogenesis 2001, 22:403-408.
36. Marchini J., Howie B., Myers S., McVean G., Donnelly P. A new multipoint method for genome-wide association studies by imputation of genotypes. Nat. Genet. 2007, 39:906-913.
37. Blankenburg S., Konig I.R., Moessner R., Laspe P., Thoms K.M., Krueger U., Khan S.G., Westphal G., Berking C., Volkenandt M., Reich K., Neumann C., Ziegler A., Kraemer K.H., Emmert S. Assessment of 3 xeroderma pigmentosum group C gene polymorphisms and risk of cutaneous melanoma: a case-control study. Carcinogenesis 2005, 26:1085-1090.
38. Sanyal S., Festa F., Sakano S., Zhang Z., Steineck G., Norming U., Wijkstrom H., Larsson P., Kumar R., Hemminki K. Polymorphisms in DNA repair and metabolic genes in bladder cancer. Carcinogenesis 2004, 25:729-734.
39. Xi T., Jones I.M., Mohrenweiser H.W. Many amino acid substitution variants identified in DNA repair genes during human population screenings are predicted to impact protein function. Genomics 2004, 83:970-979.
40. Mocellin S., Verdi D., Nitti D. DNA repair gene polymorphisms and risk of cutaneous melanoma: a systematic review and meta-analysis. Carcinogenesis 2009, 30:1735-1743.
41. Han S., Zhang H.T., Wang Z., Xie Y., Tang R., Mao Y., Li Y. DNA repair gene XRCC3 polymorphisms and cancer risk: a meta-analysis of 48 case-control studies. Eur. J. Hum. Genet. 2006, 14:1136-1144.
42. Kauffmann A., Rosselli F., Lazar V., Winnepenninckx V., Mansuet-Lupo A., Dessen P., van den Oord J.J., Spatz A., Sarasin A. High expression of DNA repair pathways is associated with metastasis in melanoma patients. Oncogene 2008, 27:565-573.
43. Figl A., Scherer D., Nagore E., Bermejo J.L., Dickes E., Thirumaran R.K., Gast A., Hemminki K., Kumar R., Schadendorf D. Single nucleotide polymorphisms in DNA repair genes XRCC1 and APEX1 in progression and survival of primary cutaneous melanoma patients. Mutat. Res. 2009, 661:78-84.
44. Friedberg E.C. How nucleotide excision repair protects against cancer. Nat. Rev. Cancer 2001, 1:22-33.
45. Friedberg E.C., Walker G.C., Siede W. DNA Repair and Mutagenesis 1995, ASM Press, Washington.
46. Vodicka P., Kumar R., Stetina R., Sanyal S., Soucek P., Haufroid V., Dusinska M., Kuricova M., Zamecnikova M., Musak L., Buchancova J., Norppa H., Hirvonen A., Vodickova L., Naccarati A., Matousu Z., Hemminki K. Genetic polymorphisms in DNA repair genes and possible links with DNA repair rates, chromosomal aberrations and single-strand breaks in DNA. Carcinogenesis 2004, 25:757-763.
47. Vodicka P., Stetina R., Polakova V., Tulupova E., Naccarati A., Vodickova L., Kumar R., Hanova M., Pardini B., Slyskova J., Musak L., De Palma G., Soucek P., Hemminki K. Association of DNA repair polymorphisms with DNA repair functional outcomes in healthy human subjects. Carcinogenesis 2007, 28:657-664.
48. Lunn R.M., Helzlsouer K.J., Parshad R., Umbach D.M., Harris E.L., Sanford K.K., Bell D.A. XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis 2000, 21:551-555.
49. Qiao Y., Spitz M.R., Guo Z., Hadeyati M., Grossman L., Kraemer K.H., Wei Q. Rapid assessment of repair of ultraviolet DNA damage with a modified host-cell reactivation assay using a luciferase reporter gene and correlation with polymorphisms of DNA repair genes in normal human lymphocytes. Mutat. Res. 2002, 509:165-174.
50. Qiao Y., Spitz M.R., Shen H., Guo Z., Shete S., Hedayati M., Grossman L., Mohrenweiser H., Wei Q. Modulation of repair of ultraviolet damage in the host-cell reactivation assay by polymorphic XPC and XPD/ERCC2 genotypes. Carcinogenesis 2002, 23:295-299.
51. Seker H., Butkiewicz D., Bowman E.D., Rusin M., Hedayati M., Grossman L., Harris C.C. Functional significance of xpd polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the xpd 312 asp/asp genotype. Cancer Res. 2001, 61:7430-7434.
52. Spitz M.R., Wu X., Wang Y., Wang L.E., Shete S., Amos C.I., Guo Z., Lei L., Mohrenweiser H., Wei Q. Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients. Cancer Res. 2001, 61:1354-1357.
53. Au W.W., Salama S.A., Sierra-Torres C.H. Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ. Health Perspect. 2003, 111:1843-1850.
54. Shi Q., Wang L.E., Bondy M.L., Brewster A., Singletary S.E., Wei Q. Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients. Carcinogenesis 2004, 25:1695-1700.
55. Duell E.J., Wiencke J.K., Cheng T.J., Varkonyi A., Zuo Z.F., Ashok T.D., Mark E.J., Wain J.C., Christiani D.C., Kelsey K.T. Polymorphisms in the DNA repair genes XRCC1 and ERCC2 and biomarkers of DNA damage in human blood mononuclear cells. Carcinogenesis 2000, 21:965-971.
56. Smith T.R., Levine E.A., Freimanis R.I., Akman S.A., Allen G.O., Hoang K.N., Liu-Mares W., Hu J.J. Polygenic model of DNA repair genetic polymorphisms in human breast cancer risk. Carcinogenesis 2008, 29:2132-2138.
57. Weiss J.M., Weiss N.S., Ulrich C.M., Doherty J.A., Voigt L.F., Chen C. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer. Cancer Epidemiol. Biomarkers Prev. 2005, 14:2524-2530.
58. Caggana M., Kilgallen J., Conroy J.M., Wiencke J.K., Kelsey K.T., Miike R., Chen P., Wrensch M.R. Associations between ERCC2 polymorphisms and gliomas. Cancer Epidemiol. Biomarkers Prev. 2001, 10:355-360.
59. Benhamou S., Sarasin A. ERCC2/XPD gene polymorphisms and lung cancer: a HuGE review. Am. J. Epidemiol. 2005, 161:1-14.
60. Chang J.S., Wrensch M.R., Hansen H.M., Sison J.D., Aldrich M.C., Quesenberry C.P., Seldin M.F., Kelsey K.T., Kittles R.A., Silva G., Wiencke J.K. Nucleotide excision repair genes and risk of lung cancer among San Francisco Bay Area Latinos and African Americans. Int. J. Cancer 2008, 123:2095-2104.
61. Kiyohara C., Yoshimasu K. Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: a meta-analysis. Int. J. Med. Sci. 2007, 4:59-71.
62. Shen M., Berndt S.I., Rothman N., Demarini D.M., Mumford J.L., He X., Bonner M.R., Tian L., Yeager M., Welch R., Chanock S., Zheng T., Caporaso N., Lan Q. Polymorphisms in the DNA nucleotide excision repair genes and lung cancer risk in Xuan Wei, China. Int. J. Cancer 2005, 116:768-773.
63. Weiss J.M., Weiss N.S., Ulrich C.M., Doherty J.A., Chen C. Nucleotide excision repair genotype and the incidence of endometrial cancer: effect of other risk factors on the association. Gynecol. Oncol. 2006, 103:891-896.
64. Shen M., Zheng T., Lan Q., Zhang Y., Zahm S.H., Wang S.S., Holford T.R., Leaderer B., Yeager M., Welch R., Kang D., Boyle P., Zhang B., Zou K., Zhu Y., Chanock S., Rothman N. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut. Hum. Genet. 2006, 119:659-668.
65. Garcia-Closas M., Malats N., Real F.X., Welch R., Kogevinas M., Chatterjee N., Pfeiffer R., Silverman D., Dosemeci M., Tardon A., Serra C., Carrato A., Garcia-Closas R., Castano-Vinyals G., Chanock S., Yeager M., Rothman N. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol. Biomarkers Prev. 2006, 15:536-542.
66. Thirumaran R.K., Bermejo J.L., Rudnai P., Gurzau E., Koppova K., Goessler W., Vahter M., Leonardi G.S., Clemens F., Fletcher T., Hemminki K., Kumar R. Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 2006, 27:1676-1681.
67. Lee S.A., Lee K.M., Park S.K., Choi J.Y., Kim B., Nam J., Yoo K.Y., Noh D.Y., Ahn S.H., Kang D. Genetic polymorphism of XRCC3 Thr241Met and breast cancer risk: case-control study in Korean women and meta-analysis of 12 studies. Breast Cancer Res. Treat. 2007, 103:71-76.
68. Garcia-Closas M., Egan K.M., Newcomb P.A., Brinton L.A., Titus-Ernstoff L., Chanock S., Welch R., Lissowska J., Peplonska B., Szeszenia-Dabrowska N., Zatonski W., Bardin-Mikolajczak A., Struewing J.P. Polymorphisms in DNA double-strand break repair genes and risk of breast cancer: two population-based studies in USA and Poland, and meta-analyses. Hum. Genet. 2006, 119:376-388.
69. Figueroa J.D., Malats N., Rothman N., Real F.X., Silverman D., Kogevinas M., Chanock S., Yeager M., Welch R., Dosemeci M., Tardon A., Serra C., Carrato A., Garcia-Closas R., Castano-Vinyals G., Garcia-Closas M. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis 2007, 28:1788-1793.
70. Thacker J. The RAD51 gene family, genetic instability and cancer. Cancer Lett. 2005, 219:125-135.
71. Matullo G., Palli D., Peluso M., Guarrera S., Carturan S., Celentano E., Krogh V., Munnia A., Tumino R., Polidoro S., Piazza A., Vineis P. XRCC1, XRCC3, XPD gene polymorphisms, smoking and (32)P-DNA adducts in a sample of healthy subjects. Carcinogenesis 2001, 22:1437-1445.
72. Kiyohara C., Takayama K., Nakanishi Y. Association of genetic polymorphisms in the base excision repair pathway with lung cancer risk: a meta-analysis. Lung Cancer 2006, 54:267-283.
73. Zhang Y., Newcomb P.A., Egan K.M., Titus-Ernstoff L., Chanock S., Welch R., Brinton L.A., Lissowska J., Bardin-Mikolajczak A., Peplonska B., Szeszenia-Dabrowska N., Zatonski W., Garcia-Closas M. Genetic polymorphisms in base-excision repair pathway genes and risk of breast cancer. Cancer Epidemiol. Biomarkers Prev. 2006, 15:353-358.
74. Pardini B., Naccarati A., Novotny J., Smerhovsky Z., Vodickova L., Polakova V., Hanova M., Slyskova J., Tulupova E., Kumar R., Bortlik M., Barale R., Hemminki K., Vodicka P. DNA repair genetic polymorphisms and risk of colorectal cancer in the Czech Republic. Mutat. Res. 2008, 638:146-153.
75. Moreno V., Gemignani F., Landi S., Gioia-Patricola L., Chabrier A., Blanco I., Gonzalez S., Guino E., Capella G., Canzian F. Polymorphisms in genes of nucleotide and base excision repair: risk and prognosis of colorectal cancer. Clin. Cancer Res. 2006, 12:2101-2108.
76. Hao B., Miao X., Li Y., Zhang X., Sun T., Liang G., Zhao Y., Zhou Y., Wang H., Chen X., Zhang L., Tan W., Wei Q., Lin D., He F. A novel T-77C polymorphism in DNA repair gene XRCC1 contributes to diminished promoter activity and increased risk of non-small cell lung cancer. Oncogene 2006, 25:3613-3620.
77. Tuimala J., Szekely G., Gundy S., Hirvonen A., Norppa H. Genetic polymorphisms of DNA repair and xenobiotic-metabolizing enzymes: role in mutagen sensitivity. Carcinogenesis 2002, 23:1003-1008.
78. Hu Z., Ma H., Chen F., Wei Q., Shen H. XRCC1 polymorphisms and cancer risk: a meta-analysis of 38 case-control studies. Cancer Epidemiol. Biomarkers Prev. 2005, 14:1810-1818.